NOVACYT
Market cap, as pointed out by a hedge fund last night, is
"Currently lower than expected cash in bank come June 2021"
Find ANY other company on the stock market in that situation and post here. #NCYT is a once in a generation stock.
#ALNOV #ODX #AVCT #GDR #SNG #N4P
Market cap, as pointed out by a hedge fund last night, is
"Currently lower than expected cash in bank come June 2021"
Find ANY other company on the stock market in that situation and post here. #NCYT is a once in a generation stock.
#ALNOV #ODX #AVCT #GDR #SNG #N4P
https://twitter.com/BrenchleyCap/status/1313024524112326657
If investors don't understand what that means, it means that Novacyt will eventually re-rate come 2021, and it will have a market capitalisation of 1 to 2 billion and keep growing.
To miss something so obvious, you will never have any credibility
To miss something so obvious, you will never have any credibility
Take a look at diagnostics companies, their revenues, and their market caps:
pharmashots.com/16995/top-20-d…
pharmashots.com/16995/top-20-d…
Then take a look at Novacyt's non-covid markets, revenue generator acquisitions, USP, current orders etc.
Non-covid market is worth 110 Billion over the next few years. Covid is only worth 22 Billion.
Novacyt has orders for around 1 Billion up to June 2021 already.
Non-covid market is worth 110 Billion over the next few years. Covid is only worth 22 Billion.
Novacyt has orders for around 1 Billion up to June 2021 already.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
